An Open-label, Randomized, Parallel-arm Study Investigating the Efficacy and Safety of Intravenous Administration of Pamrevlumab Versus Standard of Care in Patients With COVID-19
Clinical trial NCT05262309 · COMPLETED
Trial details
- NCT number
- NCT05262309
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-12
- Primary completion
- 2022-01-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.